{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:29:54Z","timestamp":1757618994409,"version":"3.44.0"},"reference-count":8,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2023,10,9]]},"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1136\/ejhpharm-2023-003733","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T13:20:14Z","timestamp":1698499214000},"page":"293-294","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Budget impact analysis: comparing the costs of nusinersen and risdiplam in the treatment of type 3 spinal muscular atrophy patients"],"prefix":"10.1136","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8522-5895","authenticated-orcid":false,"given":"Maria Elisabetta","family":"Uda","sequence":"first","affiliation":[{"name":"Hospital Pharmacy School, University of Sassari, Sassari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8541-539X","authenticated-orcid":false,"given":"Melania","family":"Rivano","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy, Ospedale Roberto Binaghi, Cagliari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Aledda","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy, Santissima Trinit\u00e0 Hospital, Cagliari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Maioli","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Centre, Ospedale Roberto Binaghi, Cagliari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Lombardo","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy, Ospedale Roberto Binaghi, Cagliari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,10,28]]},"reference":[{"key":"2025090703043510000_32.3.293.1","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-6-71","article-title":"Spinal muscular atrophy","volume":"6","author":"D\u2019Amico","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"2025090703043510000_32.3.293.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2022.04.006"},{"key":"2025090703043510000_32.3.293.3","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2174\/1381612828666220329115433","article-title":"Treatment of adult spinal muscular atrophy: overview and recent developments","volume":"28","author":"Brakemeier","year":"2022","journal-title":"Curr Pharm Des"},{"key":"2025090703043510000_32.3.293.4","unstructured":"EMA . Summary of product characteristics: nusinersen. 2017. Available: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/spinraza-epar-product-information_en.pdf"},{"key":"2025090703043510000_32.3.293.5","unstructured":"EMA . Summary of product characteristics: onasemnogene abeparvovec. 2020. Available: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/zolgensma-epar-product-information_en.pdf"},{"key":"2025090703043510000_32.3.293.6","unstructured":"EMA . Summary of product characteristics: risdiplam. 2021. Available: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/evrysdi-epar-product-information_en.pdf"},{"key":"2025090703043510000_32.3.293.7","unstructured":"Calabr\u00f2 G , Coratti G , Pera M , et al . La Gestione value-based del Paziente con Atrofia Muscolare Spinale: Il disease burden in Italia. 2021. Available: https:\/\/www.osservatoriosullasalute.it\/wp-content\/uploads\/2021\/12\/LA-GESTIONE-VALUE-BASED-DEL-PAZIENTE-CON-ATROFIA-MUSCOLARE-SPINALE.pdf"},{"key":"2025090703043510000_32.3.293.8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2022.09.643","article-title":"Ee397 budget impact analysis of risdiplam for the treatment of spinal muscular atrophy in Colombia","volume":"25","author":"V\u00e1squez","year":"2022","journal-title":"Value in Health"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2023-003733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:04:44Z","timestamp":1757239484000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2023-003733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,28]]},"references-count":8,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,4,23]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/ejhpharm-2023-003733"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2023-003733","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2023,10,28]]}}}